Literature DB >> 16470742

Molecular cytogenetic analysis of a familial interstitial deletion Xp22.2-22.3 with a highly variable phenotype in female carriers.

Sylwia Chocholska1, Eva Rossier, Gotthold Barbi, Hildegard Kehrer-Sawatzki.   

Abstract

We describe a familial interstitial deletion of 7.7-Mb involving Xp22.2-22.3. The deletion was transmitted from an asymptomatic mother to her two children with severe developmental delay, no speech development and autistic behavior. Assessment of the deletion boundaries by FISH and PCR analyses indicated that the deletions encompasses 27 genes. Several of these genes are associated with known disorders, like KAL1 (Kallmann syndrome), steroid sulfatase (STS) (X-linked ichtyosis), and arylsulfatase E (ARSE) (chondrodysplasia punctata). The deletion also includes all four VCX genes (VCX-A, VCX-B1, VCX-B, and VCX-C) and the neuroligin 4 (NLGN4) gene. VCX-A deficiency has been shown previously to be associated with mental retardation and NLGN4 mutations lead to mental retardation in conjunction with autism. Functional deficiency of both MRX genes, VCX-A and NLGN4, are most likely associated with the impaired cognitive development of the patients described here. The phenotype associated with the Xp deletion was highly variable in female carriers and might be attributed to unfavorable X inactivation. However, all the 27 genes included in the deleted interval escape X inactivation and are expressed at variable levels from the normal X chromosome. Thus, the overall X inactivation pattern and inter-individual expression variability of the genes in distal Xp might be determinants of the phenotype associated with the deletion. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16470742     DOI: 10.1002/ajmg.a.31145

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  23 in total

1.  An Autism-Associated Mutation Impairs Neuroligin-4 Glycosylation and Enhances Excitatory Synaptic Transmission in Human Neurons.

Authors:  Thomas P Cast; Daniel J Boesch; Kim Smyth; Alisa E Shaw; Michael Ghebrial; Soham Chanda
Journal:  J Neurosci       Date:  2020-12-02       Impact factor: 6.167

2.  Characterization of the solution structure of a neuroligin/beta-neurexin complex.

Authors:  Davide Comoletti; Alexander Grishaev; Andrew E Whitten; Palmer Taylor; Jill Trewhella
Journal:  Chem Biol Interact       Date:  2008-05-04       Impact factor: 5.192

3.  Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2.

Authors:  Markus Wöhr; Jill L Silverman; Maria L Scattoni; Sarah M Turner; Mark J Harris; Roheeni Saxena; Jacqueline N Crawley
Journal:  Behav Brain Res       Date:  2012-07-20       Impact factor: 3.332

4.  Whole Xp Deletion in a Girl with Mental Retardation, Epilepsy, and Biochemical Features of OTC Deficiency.

Authors:  K Joost; P Tammur; R Teek; O Zilina; M Peters; M Kreile; B Lace; R Zordania; I Talvik; K Ounap
Journal:  Mol Syndromol       Date:  2011-09-14

Review 5.  Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders.

Authors:  Emanuela Santini; Eric Klann
Journal:  Sci Signal       Date:  2014-10-28       Impact factor: 8.192

6.  Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons.

Authors:  Samuele G Marro; Soham Chanda; Nan Yang; Justyna A Janas; Giulio Valperga; Justin Trotter; Bo Zhou; Sean Merrill; Issa Yousif; Hannah Shelby; Hannes Vogel; M Yashar S Kalani; Thomas C Südhof; Marius Wernig
Journal:  Neuron       Date:  2019-06-27       Impact factor: 17.173

7.  Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders.

Authors:  M-L Jacquemont; D Sanlaville; R Redon; O Raoul; V Cormier-Daire; S Lyonnet; J Amiel; M Le Merrer; D Heron; M-C de Blois; M Prieur; M Vekemans; N P Carter; A Munnich; L Colleaux; A Philippe
Journal:  J Med Genet       Date:  2006-07-13       Impact factor: 6.318

8.  A large X-chromosomal deletion is associated with microphthalmia with linear skin defects (MLS) and amelogenesis imperfecta (XAI).

Authors:  Grace M Hobson; Carolyn W Gibson; Melissa Aragon; Zhi-an Yuan; Angelique Davis-Williams; Linda Banser; Jennifer Kirkham; Alan H Brook
Journal:  Am J Med Genet A       Date:  2009-08       Impact factor: 2.802

Review 9.  Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation.

Authors:  Audrey Guilmatre; Christèle Dubourg; Anne-Laure Mosca; Solenn Legallic; Alice Goldenberg; Valérie Drouin-Garraud; Valérie Layet; Antoine Rosier; Sylvain Briault; Frédérique Bonnet-Brilhault; Frédéric Laumonnier; Sylvie Odent; Gael Le Vacon; Géraldine Joly-Helas; Véronique David; Claude Bendavid; Jean-Michel Pinoit; Céline Henry; Caterina Impallomeni; Eva Germano; Gaetano Tortorella; Gabriella Di Rosa; Catherine Barthelemy; Christian Andres; Laurence Faivre; Thierry Frébourg; Pascale Saugier Veber; Dominique Campion
Journal:  Arch Gen Psychiatry       Date:  2009-09

10.  Molecular cytogenetic characterization of two independent karyotypic anomalies in a patient with severe mental retardation and juvenile idiopathic arthritis.

Authors:  Sabine Leybrand; Eva Rossier; Gotthold Barbi; David N Cooper; Hildegard Kehrer-Sawatzki
Journal:  Genomic Med       Date:  2007-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.